- Colgate-Palmolive reported an adjusted earnings per share (EPS) of 91 cents for Q4, surpassing estimates of 89 cents and outperforming last year’s 87 cents.
- Net sales for the quarter were $4.94 billion, slightly below the estimate of $4.97 billion and representing a decrease of 0.1% from the previous year.
- Overall pricing increased by 1.8%, which was less than the expected 2.7% growth.
- In North America, pricing fell by 2.7%, more than the anticipated decline of 2.14%.
- Latin America pricing saw an increase of 8.3%, slightly below the expected 8.5% rise.
- Prices declined by 2% in the Asia Pacific region, contrasting with the expected increase of 1.14%.
- The Hill’s unit had a pricing increase of 2%, which was less than the estimated 2.78%.
- Company comments highlighted strong sales growth and operating leverage as key factors driving improved net income and double-digit EPS growth compared to 2023.
- Analyst ratings for Colgate-Palmolive include 14 buy recommendations, 9 holds, and 3 sells.
Colgate Palmolive Co on Smartkarma
Analysts on Smartkarma are closely watching Colgate Palmolive Co, with reports from Baptista Research shedding light on different perspectives. In a report titled “Colgate-Palmolive Company: Will Its Innovation & Market Adaptation in Latin America Bring A Shift In The Competitive Dynamics? – Major Drivers”, the analyst leans bullish. The report discusses the company’s third-quarter 2024 earnings, highlighting positive aspects such as consistent top and bottom-line growth and strong organic sales expansion in both developed and emerging markets.
On the other hand, another report by Baptista Research titled “Colgate-Palmolive Company: A Bear’s Perspective On This Consumer Goods Player! – Major Drivers” provides a bearish view. This report focuses on Colgate-Palmolive’s Q2 2024 earnings, emphasizing both positive outcomes and strategic challenges. The company’s achievements in driving organic growth through marketing efforts, innovation, and data analytics are highlighted as key factors impacting its investment viability.
A look at Colgate Palmolive Co Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Colgate-Palmolive Company, a global consumer products giant known for its wide range of household and personal care items, has a mixed outlook based on Smartkarma Smart Scores. While the company shows promise in terms of dividend yield and growth potential, its value and resilience scores are slightly lower. Colgate-Palmolive’s momentum score indicates a steady performance in the market. Known for its popular brands like toothpaste, shampoos, and pet nutrition products, the company continues to maintain a strong presence in the competitive consumer goods sector.
Despite facing some challenges in areas like value and resilience, Colgate-Palmolive’s solid dividend and growth prospects, coupled with a decent momentum score, position it well for long-term success in the consumer products market. With a diverse product portfolio catering to everyday needs ranging from oral care to laundry products, Colgate-Palmolive remains a key player in the industry, leveraging its established brand presence and global reach to drive future growth and profitability.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
